sickle cell

October 15, 2020

Challenges Of Developing And Facilitating Access To New Sickle Cell Disease Therapies: Case Of The Deferoxamine Patch

Do you like it?
Read more
October 25, 2019

FDA Grants TauTona Group Orphan Drug Designation for Treatment of Sickle Cell Disease Ulcers

There is no standard of care for sickle cell patients who suffer from these debilitating wounds TauTona Group, a vertically-integrated operational venture fund focused on creating […]
Do you like it?
Read more